Release Date: 09/08/23 16:22 Summary: PDS dated 4 August 2023 Price Sensitive: No Download Document 617.3KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%